Recro Pharma, Inc.
Q4 2021 Earnings Call Transcript

Published:

  • Disclaimer*:
    This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide.
  • Operator:
    00
  • Stephanie Diaz:
    00
  • David Enloe:
    02
  • Ryan Lake:
    3
  • David Enloe:
    10
  • Operator:
    27
  • Jacob Johnson:
    27
  • David Enloe:
    28
  • Jacob Johnson:
    30
  • David Enloe:
    30
  • Jacob Johnson:
    32
  • David Enloe:
    32
  • Jacob Johnson:
    34
  • David Enloe:
    34
  • Operator:
    34
  • Matt Hewitt:
    34
  • Ryan Lake:
    35
  • Matt Hewitt:
    38
  • David Enloe:
    38
  • Matt Hewitt:
    40
  • David Enloe:
    40
  • Matt Hewitt:
    41
  • David Enloe:
    41
  • Operator:
    41
  • Christine Rains:
    41
  • Ryan Lake:
    41
  • Christine Rains:
    42
  • Ryan Lake:
    42
  • Christine Rains:
    44
  • David Enloe:
    44
  • Christine Rains:
    46
  • David Enloe:
    46
  • Operator:
    46
  • David Enloe:
    46
  • Operator:
    46

Other Recro Pharma, Inc. earnings call transcripts: